AAPL   321.62 (-0.07%)
AMZN   2,467.45 (-0.15%)
CGC   16.32 (-0.97%)
BABA   213.27 (+3.24%)
GE   7.03 (+3.99%)
TSLA   892.95 (-0.57%)
AMD   52.89 (-1.38%)
T   30.87 (-0.19%)
ACB   14.63 (+3.76%)
F   5.90 (+0.51%)
GILD   73.22 (-2.58%)
DIS   118.30 (-0.40%)
BAC   24.91 (+1.22%)
AAPL   321.62 (-0.07%)
AMZN   2,467.45 (-0.15%)
CGC   16.32 (-0.97%)
BABA   213.27 (+3.24%)
GE   7.03 (+3.99%)
TSLA   892.95 (-0.57%)
AMD   52.89 (-1.38%)
T   30.87 (-0.19%)
ACB   14.63 (+3.76%)
F   5.90 (+0.51%)
GILD   73.22 (-2.58%)
DIS   118.30 (-0.40%)
BAC   24.91 (+1.22%)
AAPL   321.62 (-0.07%)
AMZN   2,467.45 (-0.15%)
CGC   16.32 (-0.97%)
BABA   213.27 (+3.24%)
GE   7.03 (+3.99%)
TSLA   892.95 (-0.57%)
AMD   52.89 (-1.38%)
T   30.87 (-0.19%)
ACB   14.63 (+3.76%)
F   5.90 (+0.51%)
GILD   73.22 (-2.58%)
DIS   118.30 (-0.40%)
BAC   24.91 (+1.22%)
AAPL   321.62 (-0.07%)
AMZN   2,467.45 (-0.15%)
CGC   16.32 (-0.97%)
BABA   213.27 (+3.24%)
GE   7.03 (+3.99%)
TSLA   892.95 (-0.57%)
AMD   52.89 (-1.38%)
T   30.87 (-0.19%)
ACB   14.63 (+3.76%)
F   5.90 (+0.51%)
GILD   73.22 (-2.58%)
DIS   118.30 (-0.40%)
BAC   24.91 (+1.22%)
Log in

NASDAQ:AEMDAethlon Medical Stock Price, Forecast & News

$1.43
-0.04 (-2.72 %)
(As of 06/2/2020 01:55 PM ET)
Add
Compare
Today's Range
$1.41
Now: $1.43
$1.51
50-Day Range
$1.23
MA: $1.39
$1.58
52-Week Range
$0.76
Now: $1.43
$9.00
Volume1,768 shs
Average Volume401,690 shs
Market Capitalization$13.38 million
P/E RatioN/A
Dividend YieldN/A
Beta0.73
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Read More
Aethlon Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$230,000.00
Book Value$1.82 per share

Profitability

Net Income$-6,200,000.00

Miscellaneous

Employees6
Market Cap$13.38 million
Next Earnings Date7/6/2020 (Estimated)
OptionableNot Optionable

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

How has Aethlon Medical's stock been impacted by COVID-19 (Coronavirus)?

Aethlon Medical's stock was trading at $1.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AEMD shares have decreased by 28.1% and is now trading at $1.43. View which stocks have been most impacted by Coronavirus.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Monday, July 6th 2020. View our earnings forecast for Aethlon Medical.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) released its quarterly earnings results on Monday, February, 10th. The medical equipment provider reported ($0.30) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($1.03) by $0.73. The medical equipment provider earned $0.41 million during the quarter, compared to analysts' expectations of $0.19 million. View Aethlon Medical's earnings history.

Has Aethlon Medical been receiving favorable news coverage?

Headlines about AEMD stock have been trending very positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aethlon Medical earned a news sentiment score of 3.8 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutAethlon Medical.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 235,500 shares, an increase of 16.1% from the April 15th total of 202,900 shares. Based on an average trading volume of 1,280,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.6% of the company's stock are short sold. View Aethlon Medical's Current Options Chain.

Who are some of Aethlon Medical's key competitors?

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Agile Therapeutics (AGRX), Crispr Therapeutics (CRSP), Vaxart (VXRT), Protalix Biotherapeutics (PLX), vTv Therapeutics (VTVT), Amarin (AMRN), Cytosorbents (CTSO), VBI Vaccines (VBIV), OpGen (OPGN) and Senseonics (SENS).

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:
  • Mr. James B. Frakes, CFO, Sr. VP of Fin. & Sec. (Age 62)
  • Mr. James A. Joyce, Consultant (Age 57)
  • Dr. Timothy C. Rodell, Interim CEO & Director (Age 68)
  • Mr. Sunil Sawhney, Head of Clinical Studies
  • Dr. Richard H. Tullis, Consultant (Age 74)

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (0.74%).

Which major investors are buying Aethlon Medical stock?

AEMD stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.43.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $13.38 million and generates $230,000.00 in revenue each year. The medical equipment provider earns $-6,200,000.00 in net income (profit) each year or ($5.10) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is www.aethlonmedical.com.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.